Altamira Therapeutics Ltd. (CYTO) Cash Flow Annual - Discounting Cash Flows
Altamira Therapeutics Ltd.
CYTO (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing: 2023-06-30 2024-04-10 2023-05-16 2022-04-12 2021-03-31 2020-04-16 2019-03-14 2018-03-22 2017-03-14 2016-03-14 2015-03-31 2013-12-31 2012-12-31
Net Income/Starting Line -23.71 -3.87 -26.53 -17.39 -8.2 -6.63 -11.5 -24.41 -30.66 -29.71 -18.19 -15 -4.6
Cash From Operating Activities -10.81 -11.51 -8.68 -13.67 -4.84 -8.39 -13.23 -24.28 -29.45 -28.73 -19.32 -14.04 -4.5
Depreciation and Amortization 0.119 0.119 0.119 0.076 0.02 0.031 0.073 0.123 0.098 0.093 0.074 0.038 0.009
Deferred Income Tax 0 -0.1 -0.01 0.022 -0.021 -0.194 0.162 -0.018 -0.131 -1.06 -4.09 0.306 0.03
Stock Based Compensation 0.264 0 0.343 1.21 0.369 0.227 0.028 0.355 0.291 0.312 0.271 0.11 0.056
Other Non-Cash Items 12.51 -3.42 13.83 1.9 2.69 -0.601 0.475 0.142 0.679 -0.036 -0.002 0.036 -0.006
Changes in Working Capital 0.002 -4.24 3.56 0.511 0.301 -1.22 -2.47 -0.468 0.272 1.67 2.61 0.471 0.014
Accounts Receivable -0.063 0.014 -0.104 -0.34 0.254 -0.019 -0.018 0.093 0.277 -0.146 -0.018 -0.289 -0.126
Inventory -0.124 -0.32 0.828 -0.839 0 0 0 0 0 0 0 0 0
Accounts Payable -3.19 -0.014 0.104 0.34 0 0 0 -0.637 0.632 -2.03 0 0 0
Deferred Revenue 3.38 -3.92 2.73 1.35 0.046 -1.21 -3.09 0.169 -0.361 3.69 0.35 0.23 0
Other Working Capital 0 0 0 0 0 0 0.636 -0.093 -0.277 0.146 2.28 0.53 0.14
Cash From Investing Activities -0.608 1.44 -2.14 -3.51 -2.31 -3 -1.82 -0.099 -0.177 -0.043 -1.19 -0.035 -0.053
Investments in Property Plant and Equipment 0 0 -2.14 -3.33 -2.32 -3.02 -1.89 -0.153 -0.244 -0.08 -1.24 -0.109 -0.132
Payments for Acquisitions 0 1.43 0 0 0 0 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 -0.179 0 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0.01 0 0 0 0 0 0 0 0 0 0 0.073
Other Investing Activities -0.608 0.001 0.001 -0.179 0 0.018 0.068 0.054 0.068 0.037 0.052 0.074 0.006
Cash From Financing Activities 10.99 10.62 9.83 6.61 16.96 7.38 5.73 8.22 11.44 20.92 49.61 37.88 3.86
Debt Repayment 0 1.05 5.92 -0.069 1.52 -1.46 -9.27 -2.09 11.99 0 0 13.77 0
Common Stock Issued 5.89 0 0 0 0 9.79 17.45 13.04 0 21.07 50.04 24.12 3.86
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 10.99 9.57 3.91 6.68 15.44 -0.952 -2.44 -2.73 -0.548 -0.152 -0.429 -0.01 0
Effect of Forex Changes on Cash 0.111 0.047 0.024 0.289 0.072 0.008 -0.258 -1.32 0.397 1.15 3.96 -0 0.001
Net Change in Cash -0.139 0.602 -0.969 -10.27 9.87 -4.01 -9.58 -17.47 -17.8 -6.7 33.07 23.8 -0.689
Cash at Beginning of Period 0.194 0.015 0.984 11.26 1.38 5.39 14.97 32.44 50.24 56.93 23.87 0.064 0.753
Cash at End of Period 0.055 0.617 0.015 0.984 11.26 1.38 5.39 14.97 32.44 50.24 56.93 23.87 0.064
Free Cash Flow -10.81 -11.51 -10.83 -17 -7.16 -11.41 -15.12 -24.43 -29.7 -28.81 -20.55 -14.15 -4.63
Operating Cash Flow -10.81 -11.51 -8.68 -13.67 -4.84 -8.39 -13.23 -24.28 -29.45 -28.73 -19.32 -14.04 -4.5
Capital Expenditure 0 0 -2.14 -3.33 -2.32 -3.02 -1.89 -0.153 -0.244 -0.08 -1.24 -0.109 -0.132
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us